Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 425 of 465 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 04/30/09
Due: 04/30/10
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 12/31/25
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 07/01/18
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 04/22/19
End: 04/22/19
Due: 04/22/20
Phase: N/A
Priority: Normal
Start: 01/28/12
End: 09/25/13
Due: 09/25/14
Phase: N/A
Priority: Normal
Start: 11/28/17
End: 05/05/21
Due: 05/05/22
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 08/03/12
Due: 08/03/13
Phase: N/A
Priority: Normal
Start: 05/26/09
End: 04/11/12
Due: 04/11/13
Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma
Phase: N/A
Priority: Normal
Start: 02/21/18
End: 04/12/21
Due: 04/12/22
Phase: N/A
Priority: Normal
Start: 12/01/19
End: 01/01/24
Due: 01/01/25
Phase: N/A
Priority: Normal
Start: 11/18/21
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 07/01/09
End: 01/01/12
Due: 01/01/13
Phase: N/A
Priority: Normal
Start: 05/01/20
End: 04/10/23
Due: 04/10/24
HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction
Phase: N/A
Priority: Normal
Start: 11/20/23
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 05/10/21
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 02/28/29
Due: 02/28/30
Phase: N/A
Priority: Normal
Start: 01/17/11
End: 04/01/12
Due: 04/01/13
Phase: N/A
Priority: Normal
Start: 12/10/09
End: 10/10/17
Due: 10/10/18
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 02/01/09
End: 09/07/17
Due: 09/07/18
Phase: N/A
Priority: Normal
Start: 04/06/17
End: 03/30/20
Due: 03/30/21
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 02/13/15
Due: 02/13/16
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 01/25/10
Due: 01/25/11
Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children
Phase: N/A
Priority: Normal
Start: 09/18/08
End: 01/01/10
Due: 01/01/11